NICE updates type 2 diabetes guidance in England, recommending earlier use of SGLT-2 inhibitors and GLP-1 receptor agonists. Separately, a study finds SGLT2 inhibitors improve survival in Takotsubo syndrome patients.
More cancer survivors are living long enough to face lasting cardiovascular effects of treatment. Cardio-oncology clinics are managing heart failure, valvular disease and radiation-related heart disease.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07756801 |
CAPITAL OFFLOAD-SHOCK |
NOT_YET_RECRUITING | PHASE4 |
| NCT07687017 |
CRP Apheresis in Infarct-Related Cardiogenic Shock |
NOT_YET_RECRUITING | NA |
| NCT07656259 |
COMPARE-VENT Feasibility Pilot Study |
RECRUITING | NA |
| NCT07643610 |
BEAT-SHOCK Registry |
RECRUITING | |
| NCT07619144 |
OPTIMIZE 5.5 - Optimizing Impella 5.5 Outcomes Through Advanced Data Science |
RECRUITING | |
| NCT07597291 |
Cardiovascular Outcomes Registry in Cardiogenic SHOCK (COR-SHOCK) |
RECRUITING | |
| NCT07515508 |
Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE |
RECRUITING | |
| NCT07293923 |
Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock |
RECRUITING | NA |
| NCT06308055 |
Abiomed Impella RT-DAQ - Observational Study |
RECRUITING | |
| NCT06080074 |
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System |
RECRUITING | PHASE2 |
